Li et al. reported PHis-based CR-NDDSs for co-delivery vascular endothelial growth factor siRNA (VEGF siRNA) and etoposide to treat metastatic non-small cell lung cancer [67]. Here, VEGFA is linked to non-small cell lung carcinoma.